Home › Drug Product Listings › Naltrexone + bupropion

Naltrexone + bupropion

Trade Name: 
Contrave
Manufacturer/Distributor: 
Valeant Canada LP
Classification: 
Anorexigenic agents
ATC Class: 
A08AA62: bupropion and naltrexone
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2018/02/13
Date Marketed in Canada (yyyy/mm/dd): 
2018/02/13
Presentation: 
Tablet, extended release: naltrexone 8 mg, bupropion 90 mg. DIN: 02472945
Comments: 
For use as an adjunct to a calorie reduced diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity (e.g., controlled hypertension, type 2 diabetes mellitus, or dyslipidemia).
Back to: 
Drug Product Listings
  • Share this
  • Printer-friendly version
  • PDF version